NCT06142461 Safety and Immunogenicity of HPV Vaccine Administered Intradermally and Intramuscularly Via Needle-Free Injection System Status WITHDRAWN Phase PHASE2
NCT04453241 Immunogenicity and Safety Study of NBP615 in Healthy Female Status COMPLETED Phase PHASE1/PHASE2
NCT04022148 The Prospective Cohort Study to Evaluate the Preventive Efficacy of HPV Vaccine in Japanese Women Aged 27-45 Years Status UNKNOWN Phase N/A
NCT03998254 Efficacy, Immunogenicity and Safety of V503 in Chinese Women Aged 20-45 Years (V503-023) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03105856 FASTER-Tlalpan Study in Mexico: HPV Vaccination Impact on Cervical Cancer Screening Program Status COMPLETED Phase PHASE4
NCT02653118 Long-term Follow-up of Broad Spectrum Human Papillomavirus (HPV) Vaccine Study in Women (V503-021) Status ACTIVE_NOT_RECRUITING Phase N/A
NCT02114385 A Study to Compare Immune Response of V503 to Gardasil in 16- to 26-year-old Men (V503-020) Status COMPLETED Phase PHASE3
NCT02087384 HPV (Human Papilloma Virus) Vaccination After Treatment of Anal Intraepithelial Neoplasia (AIN) Status COMPLETED Phase PHASE4
NCT01914367 Study of the Molecular Mechanisms Underlying the Cross-neutralizing Capacity of AS04-adjuvanted HPV Vaccine (Cervarix®) in Comparison With the Aluminiumhydroxyphosphate Sulphate Adjuvanted HPV Vaccine (Gardasil®) Status COMPLETED Phase PHASE4
NCT01741012 Study to Determine if Gardasil Vaccine is Safe and Effective in Lupus Patients Status COMPLETED Phase PHASE1
NCT01462357 Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Human Papillomavirus (HPV) Vaccine (GSK-580299) and Merck's Gardasil Vaccine When Administered According to Alternative 2-dose Schedules in 9-14 Year Old Females Status COMPLETED Phase PHASE3
NCT01461993 A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17 Status COMPLETED Phase PHASE2
NCT01386164 Immune Response to Bivalent and Tetravalent Human Papillomavirus Vaccine in HIV Infected Adults Status COMPLETED Phase PHASE4
NCT01338051 The Development of a "Mother/Child, Screen, Treat and Vaccinate Program" in Manchay and Iquitos, Peru Status COMPLETED Phase PHASE1
NCT01304498 Immunogenicity and Tolerability of V503 Versus GARDASIL (V503-009) Status COMPLETED Phase PHASE3
NCT01133509 A Model for Implementation of Cervical Cancer Screening and HPV Vaccination the Emergency Department: a Pilot Study Status UNKNOWN Phase NA
NCT00956553 Reactogenicity Study of Cervarix and Gardasil in UK Adolescent Girls Status COMPLETED Phase PHASE4
NCT00925288 Acceptability of Human Papillomavirus (HPV) Vaccine in Female Sex Workers Status COMPLETED Phase PHASE4